2m 2m 2m 2m 2m 2m 2m
RECURSN PHARMA-A (RXRX)
NASDAQ
$4.11+$0.04 (+1.01%)
Price as of Oct 02, 2026 5:49 PM EDT- $2.2BMarket Cap
- -26.27%1-Year Change
- BiotechnologyIndustry
RECURSN PHARMA-A (RXRX)
$4.11+$0.04 (+1.01%)
RXRX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $4.07 | ||
Change | -$0.06 (-1.45%) | ||
Open | $4.07 | ||
High | $4.17 | ||
Low | $3.96 | ||
Previous Close | $4.13 | ||
Volume | 17,484,139 | ||
30-Day Average Volume | 20,328,147 | ||
1-Week Change | 4.63% | ||
1-Month Change | 22.22% | ||
1-Year Change | -26.27% | ||
3-Year Change | -46.80% | ||
5-Year Change | -81.38% | ||
Fundamentals | |||
Shares Outstanding | 535.3M | ||
Total Assets | $1.2B | ||
Market Cap | $2.2B | ||
Enterprise Value | $1.6B | ||
Period: QTR TTM FY | |||
Revenue | $7.3M | ||
Net Income | -$131.0M | ||
Free Cash Flow | -$106.0M | ||
EBIT | -$131.0M | ||
EBITDA | -$112.8M | ||
Net Working Capital | $483.6M | ||
EPS | -$0.25 | ||
Enterprise Value/EBITDA | -15 | ||
Enterprise Value/Revenue | 226 | ||
P/B | 2 | ||
P/E | -16 | ||
PEG | 1 | ||
Price/Free Cash Flow | -21 | ||
Price/Operating Cash Flow | -21 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue